**Abstract**

Protocatechuic acid (PCA) is a common bioactive polyphenolic in medicinal plants and human diet. The various pharmacological activities such as antioxidant, anticancer, antidiabetic and anti-inflammatory, have been identified ^1^. However, the studies focused on the analgesic effect of this polyphenolic are limited^2^ and the action mechanisms of PCA still remain unclear.

Previously, we found that PCA has a central analgesic effect in hot-plate and tail-immersion test at the doses of 75, 150 and 300 mg/kg^3^. This study aimed to investigate the involvement of noradrenergic, serotonergic, cholinergic and opioidergic mechanisms in PCA-induced central analgesia in mice. The mice administered 300 mg/kg PCA (p.o.) were pre-treated with α~2~-adrenoceptor antagonist yohimbine (1 mg/kg, i.p.), serotonin 5-HT~2A/2C~ receptor antagonist ketanserin (1 mg/kg, i.p.), non-specific muscarinic antagonist atropine (5 mg/kg, i.p.) and non-specific opioid antagonist naloxone (5 mg/kg, i.p.), respectively. The analgesia test procedures were performed 45 minutes after PCA administration. The hot-plate (integrated supraspinal response) and tail-immersion (spinal reflex) tests were used and pain thresholds which are indicated by the withdrawal response latency to the thermal stimuli^4^ were evaluated.

The enhancement in the latency of PCA-induced response to thermal stimuli was reversed by yohimbine and naloxone pre-treatments in hot-plate test, while it was reversed by yohimbine, naloxone and also atropine in tail-immersion test.

These results indicated that PCA induces central antinociception via spinally/supraspinally mediated noradrenergic, opioidergic and spinally mediated cholinergic modulation. However, further studies are required to understand how PCA organizes the interactions of these modulatory systems.
